Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes
This is the third major regulatory milestone for the vaccine candidate following acceptance of regulatory submissions in Europe and Japan
Subscribe To Our Newsletter & Stay Updated
